MEDS Old Analysis
| MEDSDelisted Stock | USD 7.46 0.56 8.12% |
MEDS Old is overvalued with Real Value of 7.09 and Hype Value of 7.46. The main objective of MEDS Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what MEDS Old is worth, separate from its market price. There are two main types of MEDS Old's stock analysis: fundamental analysis and technical analysis.
The MEDS Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. MEDS Old is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. MEDS Stock trading window is adjusted to America/New York timezone.
MEDS |
MEDS Stock Analysis Notes
About 62.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDS Old recorded a loss per share of 24.38. The entity last dividend was issued on the 19th of July 2024. The firm had 1:15 split on the 22nd of June 2023. TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people. To find out more about MEDS Old contact the company at (800) 261-0281 or learn more at https://www.trxadehealth.com.MEDS Old Investment Alerts
| MEDS Old is now traded under the symbol SCNX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| MEDS Old is not yet fully synchronised with the market data | |
| MEDS Old has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.27 M. Net Loss for the year was (13.72 M) with profit before overhead, payroll, taxes, and interest of 4.58 M. | |
| MEDS Old currently holds about 962.23 K in cash with (2.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 62.0% of the company outstanding shares are owned by corporate insiders |
MEDS Old Upcoming and Recent Events
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
MEDS Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.28 M.MEDS Profitablity
The company has Profit Margin (PM) of 0.57 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (79.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $79.99.MEDS Old Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDS Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDS Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDS Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Augusta Gary over three months ago Disposition of tradable shares by Augusta Gary of Trxade subject to Rule 16b-3 | ||
Peterson Michael L over three months ago Disposition of tradable shares by Peterson Michael L of Trxade subject to Rule 16b-3 | ||
Fell Donald G. over six months ago Disposition of 500 shares by Fell Donald G. of Trxade at 5.3 subject to Rule 16b-3 | ||
Doss Howard A. over six months ago Insider Trading | ||
Prashant Patel over six months ago Acquisition by Prashant Patel of 10000 shares of Trxade subject to Rule 16b-3 | ||
Jennings Christine L. over six months ago Acquisition by Jennings Christine L. of 10912 shares of Trxade at 3.78 subject to Rule 16b-3 | ||
Surendra Ajjarapu over six months ago Acquisition by Surendra Ajjarapu of 150000 shares of Trxade subject to Rule 16b-3 | ||
Prashant Patel over a year ago Acquisition by Prashant Patel of 100000 shares of Trxade subject to Rule 16b-3 | ||
Janet Huffman over a year ago Acquisition by Janet Huffman of 50000 shares of Trxade subject to Rule 16b-3 |
MEDS Old Predictive Daily Indicators
MEDS Old intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MEDS Old stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About MEDS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MEDS Old prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEDS shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as MEDS Old. By using and applying MEDS Stock analysis, traders can create a robust methodology for identifying MEDS entry and exit points for their positions.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MEDS Old to your portfolios without increasing risk or reducing expected return.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in MEDS Stock
If you are still planning to invest in MEDS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEDS Old's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |